{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:23:43Z","timestamp":1770409423414,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Centre for Addiction Studies","award":["62-01619-0027"],"award-info":[{"award-number":["62-01619-0027"]}]},{"name":"the Office of the Narcotics Control Board","award":["\u0e22\u0e18 1118 (\u0e01\u0e17.)\/5559"],"award-info":[{"award-number":["\u0e22\u0e18 1118 (\u0e01\u0e17.)\/5559"]}]},{"DOI":"10.13039\/501100010034","name":"Walailak University","doi-asserted-by":"crossref","award":["WU-IRG-63-027 and New Strategic Research (P2P) project"],"award-info":[{"award-number":["WU-IRG-63-027 and New Strategic Research (P2P) project"]}],"id":[{"id":"10.13039\/501100010034","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35524-3","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:06:09Z","timestamp":1768557969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hematological and clinical-chemistry parameters of kratom users: a comparative study of users and non-users in Southern Thailand"],"prefix":"10.1038","volume":"16","author":[{"given":"Aroon","family":"La-up","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udomsak","family":"Saengow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apinun","family":"Aramrattana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"35524_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/968786","volume":"2015","author":"E Cinosi","year":"2015","unstructured":"Cinosi, E. et al. Following \u201cthe Roots\u201d of Kratom (Mitragyna speciosa): The evolution of an enhancer from a traditional use to increase work and productivity in southeast Asia to a recreational psychoactive drug in western countries. Biomed. Res. Int. 2015, 968786. https:\/\/doi.org\/10.1155\/2015\/968786 (2015).","journal-title":"Biomed. Res. Int."},{"key":"35524_CR2","first-page":"792","volume":"112","author":"WC Prozialeck","year":"2012","unstructured":"Prozialeck, W. C., Jivan, J. K. & Andurkar, S. V. Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects. J. Am. Osteopath. Assoc. 112, 792\u2013799 (2012).","journal-title":"J. Am. Osteopath. Assoc."},{"key":"35524_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuropharm.2017.08.026","volume":"134","author":"AC Kruegel","year":"2018","unstructured":"Kruegel, A. C. & Grundmann, O. The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology 134, 108\u2013120. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.026 (2018).","journal-title":"Neuropharmacology"},{"key":"35524_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/sar.S164261","volume":"10","author":"C Veltri","year":"2019","unstructured":"Veltri, C. & Grundmann, O. Current perspectives on the impact of Kratom use. Subst Abuse Rehabil 10, 23\u201331. https:\/\/doi.org\/10.2147\/sar.S164261 (2019).","journal-title":"Subst Abuse Rehabil"},{"key":"35524_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40122-020-00151-x","volume":"9","author":"SC Eastlack","year":"2020","unstructured":"Eastlack, S. C., Cornett, E. M. & Kaye, A. D. Kratom-pharmacology, clinical implications, and outlook: A comprehensive review. Pain Ther. 9, 55\u201369. https:\/\/doi.org\/10.1007\/s40122-020-00151-x (2020).","journal-title":"Pain Ther."},{"key":"35524_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jep.2017.12.017","volume":"214","author":"D Singh","year":"2018","unstructured":"Singh, D. et al. Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia. J. Ethnopharmacol. 214, 197\u2013206. https:\/\/doi.org\/10.1016\/j.jep.2017.12.017 (2018).","journal-title":"J. Ethnopharmacol."},{"key":"35524_CR7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1080\/10826084.2023.2215301","volume":"58","author":"D Saingam","year":"2023","unstructured":"Saingam, D. et al. The health impact of long-term Kratom (Mitragyna Speciosa) use in southern Thailand. Subst. Use Misuse 58, 1212\u20131225. https:\/\/doi.org\/10.1080\/10826084.2023.2215301 (2023).","journal-title":"Subst. Use Misuse"},{"key":"35524_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06931","volume":"7","author":"A La-Up","year":"2021","unstructured":"La-Up, A., Saengow, U. & Aramrattana, A. High serum high-density lipoprotein and low serum triglycerides in Kratom users: A study of Kratom users in Thailand. Heliyon 7, e06931. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06931 (2021).","journal-title":"Heliyon"},{"key":"35524_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09468","volume":"8","author":"A La-Up","year":"2022","unstructured":"La-Up, A., Wongrith, P., Chaichan, W., Aramrattana, A. & Saengow, U. Association between kratom (Mitragyna speciosa) use and metabolic syndrome. Heliyon 8, e09468. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09468 (2022).","journal-title":"Heliyon"},{"key":"35524_CR10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ 335, 806\u2013808. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD (2007).","journal-title":"BMJ"},{"key":"35524_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/02791072.2013.844532","volume":"45","author":"S Trakulsrichai","year":"2013","unstructured":"Trakulsrichai, S. et al. Kratom abuse in Ramathibodi Poison Center, Thailand: A five-year experience. J. Psychoactive Drugs 45, 404\u2013408. https:\/\/doi.org\/10.1080\/02791072.2013.844532 (2013).","journal-title":"J. Psychoactive Drugs"},{"key":"35524_CR12","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.12998\/wjcc.v9.i20.5490","volume":"9","author":"VR Ballotin","year":"2021","unstructured":"Ballotin, V. R. et al. Herb-induced liver injury: Systematic review and meta-analysis. World J. Clin. Cases 9, 5490\u20135513. https:\/\/doi.org\/10.12998\/wjcc.v9.i20.5490 (2021).","journal-title":"World J. Clin. Cases"},{"key":"35524_CR13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.4254\/wjh.v12.i10.863","volume":"12","author":"D Gandhi","year":"2020","unstructured":"Gandhi, D., Ahuja, K., Quade, A., Batts, K. P. & Patel, L. Kratom induced severe cholestatic liver injury histologically mimicking primary biliary cholangitis: A case report. World J. Hepatol. 12, 863\u2013869. https:\/\/doi.org\/10.4254\/wjh.v12.i10.863 (2020).","journal-title":"World J. Hepatol."},{"key":"35524_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.drugalcdep.2014.03.017","volume":"139","author":"D Singh","year":"2014","unstructured":"Singh, D., M\u00fcller, C. P. & Vicknasingam, B. K. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug Alcohol Depend. 139, 132\u2013137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.03.017 (2014).","journal-title":"Drug Alcohol Depend."},{"key":"35524_CR15","doi-asserted-by":"publisher","first-page":"117954762211328","DOI":"10.1177\/11795476221132824","volume":"15","author":"Y Thewjitcharoen","year":"2022","unstructured":"Thewjitcharoen, Y., Krittiyawong, S., Nakasatien, S. & Himathongkam, T. Kratom-associated mixed cholestatic-hepatocellular liver injury in a patient with long COVID: A case report. Clin. Med. Insights Case Rep. 15, 11795476221132824. https:\/\/doi.org\/10.1177\/11795476221132824 (2022).","journal-title":"Clin. Med. Insights Case Rep."},{"key":"35524_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2215\/cjn.02870707","volume":"3","author":"AC Baxmann","year":"2008","unstructured":"Baxmann, A. C. et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin. J. Am. Soc. Nephrol. 3, 348\u2013354. https:\/\/doi.org\/10.2215\/cjn.02870707 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"35524_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1467-789x.2001.00031.x","volume":"2","author":"AM Prentice","year":"2001","unstructured":"Prentice, A. M. & Jebb, S. A. Beyond body mass index. Obes. Rev. 2, 141\u2013147. https:\/\/doi.org\/10.1046\/j.1467-789x.2001.00031.x (2001).","journal-title":"Obes. Rev."},{"key":"35524_CR18","volume-title":"Modern Epidemiology","author":"KJ Rothman","year":"2008","unstructured":"Rothman, K. J., Greenland, S. & Lash, T. L. Modern Epidemiology Vol. 3 (Wolters Kluwer Health\/Lippincott Williams & Wilkins Philadelphia, 2008)."},{"key":"35524_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/jcm8060775","volume":"8","author":"U Keller","year":"2019","unstructured":"Keller, U. Nutritional laboratory markers in malnutrition. J. Clin. Med. 8, 775. https:\/\/doi.org\/10.3390\/jcm8060775 (2019).","journal-title":"J. Clin. Med."},{"key":"35524_CR20","volume-title":"Goodman & Gilman\u2019s : The Pharmacological Basis of Therapeutics","author":"BC Knollmann","year":"2023","unstructured":"Knollmann, B. C. & Brunton, L. L. Goodman & Gilman\u2019s\u202f: The Pharmacological Basis of Therapeutics Vol. 13 (McGraw-Hill Education New York, 2023)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35524-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35524-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35524-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:33:45Z","timestamp":1770370425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35524-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35524"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35524-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was reviewed and approved by the Institutional Review Board of Walailak University. The protocol number: WU-EC-AH-2-144-63. All procedures involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments. Written informed consent was obtained from all participants before data collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"5314"}}